3
Announcements
Trials
Browse
Landscape
Status
Completed
6
Recruiting
4
Terminated
2
Unknown
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
118
Tumor-Agnostic
88
Breast
55
Genitourinary
33
Thoracic
31
Head & Neck
28
Dermatologic
24
CNS
20
Gynecologic
17
Sarcoma
13
Endocrine
12
Lymphoid
7
Other hematologic neoplasm
6
NET
5
Other solid neoplasm
3
Classical hematology
2
Plasma cell
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
92
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Myeloid, Acute
79
Leukemia
41
Myeloproliferative Disorders
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Multiple Myeloma
21
Leukemia, Myeloid, Chronic-Phase
20
Lymphoma, Non-Hodgkin
18
Lymphoma
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Leukemia, Myelomonocytic, Chronic
16
Hodgkin Disease
14
Polycythemia Vera
13
Lymphoma, Large B-Cell, Diffuse
11
Primary Myelofibrosis
10
Neoplasms, Plasma Cell
10
Lymphoma, Follicular
10
Hematologic Neoplasms
10
Burkitt Lymphoma
10
Recurrence
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Anemia, Refractory, with Excess of Blasts
9
Myelodysplastic-Myeloproliferative Diseases
8
Mastocytosis
8
Lymphoma, Mantle-Cell
8
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Accelerated Phase
8
Congenital Abnormalities
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
Myeloid
×
Clear all
NCT05154474
2022-05-03
SPACE2
Weprom
Unknown
150 enrolled